The liquid biopsy sector plays a significant role in supporting modern precision oncology by providing non-invasive alternatives to traditional tissue biopsies for cancer detection, monitoring, and treatment selection. Diagnostics companies are increasingly incorporating next-generation sequencing and advanced bioinformatics that improve test sensitivity and clinical utility. The growing shift...